GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
49.51
+0.83 (1.71%)
At close: Oct 30, 2026, 4:00 PM EDT
49.60
+0.09 (0.18%)
After-hours: Oct 30, 2026, 7:49 PM EDT

GSK Revenue

GSK had revenue of 8.89B GBP in the quarter ending September 30, 2026, with 3.98% growth. This brings the company's total for the last twelve months to 33.54B, up 4.28% year-over-year. In the year 2025, GSK had annual revenue of 32.67B with 4.11% growth.

Revenue (ttm)
33.54B GBP
Revenue Growth
+4.28%
P/S Ratio
2.24
Revenue / Employee
501,833 GBP
Employees
66,841
Market Cap
99.63B USD

Revenue Chart

* This company reports financials in GBP.

Revenue by Segment

By Segment

Chart
  • HIV 7.69B 23.5%
  • Respiratory 7.07B 21.6%
  • Respiratory, Immunology and Inflammation 3.81B 11.7%
  • Shingles 3.56B 10.9%
  • Other Paediatric & Adult Vaccines 3.12B 9.6%
  • Other General Medicines 2.97B 9.1%
  • Oncology 1.98B 6.1%
  • Other 2.48B 7.6%

By Geography

Chart
  • US 16.86B 51.6%
  • International 8.28B 25.3%
  • Europe 7.53B 23.1%
Fiscal year ended Dec 31, 2025 See the full GSK breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202532.67B1.29B4.11%
Dec 31, 202431.38B1.05B3.46%
Dec 31, 202330.33B1.00B3.42%
Dec 31, 202229.32B4.63B18.74%
Dec 31, 202124.70B-9.40B-27.58%
Dec 31, 202034.10B345.00M1.02%
Dec 31, 201933.75B2.93B9.52%
Dec 31, 201830.82B635.00M2.10%
Dec 31, 201730.19B2.30B8.24%
Dec 31, 201627.89B3.97B16.58%
Dec 31, 201523.92B917.00M3.99%
Dec 31, 201423.01B-3.50B-13.20%
Dec 31, 201326.51B74.00M0.28%
Dec 31, 201226.43B-956.00M-3.49%
Dec 31, 201127.39B-1.01B-3.54%
Dec 31, 201028.39B24.00M0.08%
Dec 31, 200928.37B4.02B16.49%
Dec 31, 200824.35B1.64B7.20%
Dec 31, 200722.72B-509.00M-2.19%
Dec 31, 200623.23B1.57B7.23%
Dec 31, 200521.66B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Merck & Co.67.38B
AbbVie66.01B
Pfizer63.70B
AstraZeneca62.38B
Novartis AG57.36B
Sanofi55.89B
Novo Nordisk50.34B
Bristol-Myers Squibb Company50.03B
Revenue Rankings